ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 102,33
0,13%
Dow Jones
39 062,60
-1,53%
DAX
18 691,32
0,05%
Brent Oil
81,085
-0,55%
Bitcoin
67 329,89
-2,57%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Lantern Pharma Inc (LTRN)

  7. Lantern Pharma Inc (LTRN) Actualités

LTRN Lantern Pharma Inc

6,19
-0,27 (-4,18%)
Dernière mise à jour : 20:52:13
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Lantern Pharma Inc LTRN NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,27 -4,18% 6,19 20:52:13
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
6,47 6,1521 6,59 6,46
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
13/5/202407:30BWOregon Therapeutics et Lantern Pharma lancent une..
09/5/202422:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:02BWLantern Pharma Reports First Quarter 2024 Financial Results..
06/5/202409:00BWOregon Therapeutics & Lantern Pharma Launch Strategic AI..
02/5/202413:30BWLantern Pharma to Report First Quarter 2024 Operating &..
24/4/202414:00BWLantern Pharma Launches “Webinar Wednesdays” Featuring..
22/4/202414:12BWLantern Pharma Receives Regulatory Approval to Expand..
18/3/202421:02BWLantern Pharma Reports Fourth Quarter & Fiscal Year 2023..
18/3/202412:12IHMARKETNEWSAnticipation Builds on Wall Street for Federal Reserve’s..
15/3/202413:00BWLantern Pharma Announces Initial Patients Dosed in..
11/3/202412:30BWLantern Pharma to Report Fourth Quarter and Fiscal Year 2023..
05/3/202414:01BWLantern To Participate in H.C Wainwright & Co.’s (HCW) 1st..
04/3/202414:01BWLantern Pharma's A.I. Platform, RADR®, Surpasses 60 Billion..
01/3/202403:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
15/2/202414:01BWLantern Pharma Advances Unique ADC (Antibody Drug Conjugate)..
19/1/202422:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202413:30BWStarlight Therapeutics, a Subsidiary of Lantern Pharma..
29/12/202322:05EDGAR2Form 8-K - Current report
01/12/202312:02EDGAR2Form SC 13D/A - General statement of acquisition of..
01/12/202312:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/11/202314:00BWFDA Grants Lantern Pharma Orphan Drug Designation for Drug..
24/11/202322:05EDGAR2Form 8-K - Current report
08/11/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:05EDGAR2Form 8-K - Current report
08/11/202322:01BWLantern Pharma Reports Third Quarter 2023 Financial Results..
01/11/202313:00BWLantern Pharma to Report Third Quarter 2023 Operating &..
20/10/202323:25EDGAR2Form 8-K - Current report
10/10/202314:00BWLantern Pharma to Present at the ThinkEquity Conference on..
03/10/202314:00BWLantern Pharma Announces Publication in Clinical Cancer..
25/9/202314:30BWLantern Pharma Announces First Patient Dosed in the Phase 1..
18/9/202315:00BWLantern Pharma Receives IND Clearance from FDA Enabling..
31/8/202314:00BWLantern Pharma to Present Data Highlighting the Anti-Tumor..
28/8/202314:00BWLantern Pharma Expands AI Capabilities of RADR® Platform to..
14/8/202314:30BWLantern Pharma Receives Notice of US Patent Allowance for..
09/8/202322:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202322:05EDGAR2Form 8-K - Current report
09/8/202322:01BWLantern Pharma Reports Second Quarter 2023 Financial Results..
02/8/202314:00BWLantern Pharma to Report Second Quarter 2023 Operating &..
17/7/202314:00BWLantern Pharma to Participate and Present at Multiple..
26/6/202314:30BWOncotarget Publishes New Data by Lantern Pharma, an AI..
12/6/202314:30BWLantern Pharma Receives FDA Clearance of IND Application for..
08/6/202315:00BWLantern Pharma Leverages AI Platform, RADR®, to Develop..

Dernières Valeurs Consultées

NASDAQ
LTRN
Lantern Pharma
BIT
NSCIT6899487
Romania
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés